Prednisolone treatment induces tolerogenic dendritic cells and a regulatory milieu in myasthenia gravis patients

Journal of Immunology

Volumn 183, Issue 2, 2009, Pages 841-848

  Luther, Claudia ^a,c   Adamopoulou, Eleni ^b   Stoeckle, Christina ^a   Brucklacher Waldert, Verena ^d   Rosenkranz, Daniela ^a   Stoltze, Lars ^a   Lauer, Sigrid ^a   Poeschel, Simone ^a   Melms, Arthur ^a   Tolosa, Eva ^a,d  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c BRITISH COLUMBIA CANCER AGENCY   (Canada)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CHOLINESTERASE INHIBITOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 23; LIPOPOLYSACCHARIDE; PREDNISOLONE; INTERLEUKIN DERIVATIVE;

ADULT; AGED; ARTICLE; CD4+ T LYMPHOCYTE; CELL CULTURE; CELL FUNCTION; CELL ISOLATION; CELL MATURATION; CELL PROLIFERATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DONOR; ENVIRONMENT; HUMAN; HUMAN CELL; IMMUNOREGULATION; IN VITRO STUDY; INFLAMMATION; MONOCYTE; MYASTHENIA GRAVIS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; UPREGULATION; AUTOIMMUNITY; CASE CONTROL STUDY; COCULTURE; DRUG EFFECT; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; MIDDLE AGED; SECRETION;

ADULT; AGED; AGED, 80 AND OVER; AUTOIMMUNITY; CASE-CONTROL STUDIES; CELL PROLIFERATION; COCULTURE TECHNIQUES; DENDRITIC CELLS; HUMANS; IMMUNE TOLERANCE; INTERLEUKINS; LIPOPOLYSACCHARIDES; MIDDLE AGED; MYASTHENIA GRAVIS; PREDNISOLONE; T-LYMPHOCYTES, REGULATORY;

EID: 70249137304     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0802046     Document Type: Article

References (59)

1. Danke, N. A., D. M. Koelle, C. Yee, S. Beheray, and W. W. Kwok. 2004. Autoreactive T cells in healthy individuals. J. Immunol. 172: 5967-5972.
2. + regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6: 345-352.
3. +-regulatory T cells from mouse to man. Scand. J. Immunol. 62: 1-15.
4. + T cells in thymus, cord and adult blood. Immunology 106: 190-199.
5. Hori, S., T. Nomura, and S. Sakaguchi. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061. (Pubitemid 36222930)
6. Ziegler, S. F. 2006. FOXP3: of mice and men. Annu. Rev. Immunol. 24: 209-226.
7. Fontenot, J. D., J. P. Rasmussen, M. A. Gavin, and A. Y. Rudensky. 2005. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6: 1142-1151.
8. Gregori, S., R. Bacchetta, L. Passerini, M. K. Levings, and M. G. Roncarolo. 2007. Isolation, expansion, and characterization of human natural and adaptive regulatory T cells. Methods Mol. Biol. 380: 83-105.
9. Mahnke, K., E. Schmitt, L. Bonifaz, A. H. Enk, and H. Jonuleit. 2002. Immature, but not inactive: the tolerogenic function of immature dendritic cells. Immunol. Cell Biol. 80: 477-483.
10. Adorini, L., N. Giarratana, and G. Penna. 2004. Pharmacological induction of tolerogenic dendritic cells and regulatory T cells. Semin. Immunol. 16: 127-134.
11. Levings, M. K., and M. G. Roncarolo. 2000. T-regulatory 1 cells: a novel subset of CD4 T cells with immunoregulatory properties. J. Allergy Clin. Immunol. 106: S109-S112.
12. Jonuleit, H., and E. Schmitt. 2003. The regulatory T cell family: distinct subsets and their interrelations. J. Immunol. 171: 6323-6327. (Pubitemid 37532056)
13. Lan, R. Y., A. A. Ansari, Z. X. Lian, and M. E. Gershwin. 2005. Regulatory T cells: development, function and role in autoimmunity. Autoimmun. Rev. 4: 351-363.
14. Powrie, F., S. Read, C. Mottet, H. Uhlig, and K. Maloy. 2003. Control of immune pathology by regulatory T cells. Novartis Found. Symp. 252: 92-98; discussion 105: 106-114.
15. + regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 199: 971-979.
16. Kukreja, A., G. Cost, J. Marker, C. Zhang, Z. Sun, K. Lin-Su, S. Ten, M. Sanz, M. Exley, B. Wilson, et al. 2002. Multiple immuno-regulatory defects in type-1 diabetes. J. Clin. Invest. 109: 131-140.
17. + T-cells from patients with type 1 diabetes. Diabetes 54: 92-99.
18. + T cells from the target organ of patients with rheumatoid arthritis. Eur. J. Immunol. 33: 215-223.
19. Vincent, A. 2002. Unravelling the pathogenesis of myasthenia gravis. Nat. Rev. Immunol. 2: 797-804.
20. Melms, A., B. C. Schalke, T. Kirchner, H. K. Muller-Hermelink, E. Albert, and H. Wekerle. 1988. Thymus in myasthenia gravis: isolation of T-lymphocyte lines specific for the nicotinic acetylcholine receptor from thymuses of myasthenic patients. J. Clin. Invest. 81: 902-908.
21. Newsom-Davis, J., N. Willcox, G. Scadding, L. Calder, and A. Vincent. 1981. Anti-acetylcholine receptor antibody synthesis by cultured lymphocytes in myasthenia gravis: thymic and peripheral blood cell interactions. Ann. NY Acad. Sci. 377: 393-402.
22. Vincent, A., J. Palace, and D. Hilton-Jones. 2001. Myasthenia gravis. Lancet 357: 2122-2128.
23. Paliogianni, F., S. S. Ahuja, J. P. Balow, J. E. Balow, and D. T. Boumpas. 1993. Novel mechanism for inhibition of human T cells by glucocorticoids: glucocorticoids inhibit signal transduction through IL-2 receptor. J. Immunol. 151: 4081-4089.
24. Vanderheyde, N., V. Verhasselt, M. Goldman, and F. Willems. 1999. Inhibition of human dendritic cell functions by methylprednisolone. Transplantation 67: 1342-1347.
25. Luther, C., S. Poeschel, M. Varga, A. Melms, and E. Tolosa. 2005. Decreased frequency of intrathymic regulatory T cells in patients with myasthenia-associated thymoma. J. Neuroimmunol. 164: 124-128.
26. + T cells in the thymus of patients with autoimmune myasthenia gravis. Blood 105: 735-741.
27. + regulatory T cells. J. Immunol. 175: 4180-4183.
28. Jonuleit, H., E. Schmitt, K. Steinbrink, and A. H. Enk. 2001. Dendritic cells as a tool to induce anergic and regulatory T cells. Trends Immunol. 22: 394-400. (Pubitemid 32673646)
29. + regulatory T cells. Nat. Immunol. 4: 330-336.
30. Torgerson, T. R., and H. D. Ochs. 2007. Immune dysregulation, polyendocrinopathy, enteropathy: X-linked: forkhead box protein 3 mutations and lack of regulatory T cells. J. Allergy Clin. Immunol. 120: 744-750; quiz, 751-742.
31. Ochs, H. D., E. Gambineri, and T. R. Torgerson. 2007. IPEX, FOXP3 and regulatory T-cells: a model for autoimmunity. Immunol. Res. 38: 112-121.
32. Rosenkranz, D., S. Weyer, E. Tolosa, A. Gaenslen, D. Berg, T. Leyhe, T. Gasser, and L. Stoltze. 2007. Higher frequency of regulatory T cells in the elderly and increased suppressive activity in neurodegeneration. J. Neuroimmunol. 188: 117-127.
33. Allan, S. E., S. Q. Crome, N. K. Crellin, L. Passerini, T. S. Steiner, R. Bacchetta, M. G. Roncarolo, and M. K. Levings. 2007. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int. Immunol. 19: 345-354.
34. + FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-β dependent but does not confer a regulatory phenotype. Blood 110: 2983-2990.
35. + Tregs. J. Clin. Invest. 115: 3276-3284.
36. Boumpas, D. T., G. P. Chrousos, R. L. Wilder, T. R. Cupps, and J. E. Balow. 1993. Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates. Ann. Intern. Med. 119: 1198-1208.
37. Woltman, A. M., J. W. de Fijter, S. W. Kamerling, L. C. Paul, M. R. Daha, and C. van Kooten. 2000. The effect of calcineurin inhibitors and corticosteroids on the differentiation of human dendritic cells. Eur. J. Immunol. 30: 1807-1812.
38. Kovalovsky, D., D. Refojo, F. Holsboer, and E. Arzt. 2000. Molecular mechanisms and Th1/Th2 pathways in corticosteroid regulation of cytokine production. J. Neuroimmunol. 109: 23-29.
39. Garcia-Carrasco, M., R. O. Escarcega, S. Fuentes-Alexandro, C. Riebeling, and R. Cervera. 2007. Therapeutic options in autoimmune myasthenia gravis. Autoimmun. Rev. 6: 373-378.
40. Steinman, R. M., and J. Banchereau. 2007. Taking dendritic cells into medicine. Nature 449: 419-426.
41. Steinman, R. M. 2007. Dendritic cells: understanding immunogenicity. Eur. J. Immunol. 37 Suppl. 1: S53-S60.
42. + regulatory T cells in vivo in humans. Blood 100: 174-177.
43. + T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 192: 1213-1222.
44. Piemonti, L., P. Monti, P. Allavena, M. Sironi, L. Soldini, B. E. Leone, C. Socci, and V. Di Carlo. 1999. Glucocorticoids affect human dendritic cell differentiation and maturation. J. Immunol. 162: 6473-6481.
45. Matyszak, M. K., S. Citterio, M. Rescigno, and P. Ricciardi-Castagnoli. 2000. Differential effects of corticosteroids during different stages of dendritic cell maturation. Eur. J. Immunol. 30: 1233-1242.
46. Adorini, L. 2003. Cytokine-based immunointervention in the treatment of autoimmune diseases. Clin. Exp. Immunol. 132: 185-192.
47. Langrish, C. L., B. S. McKenzie, N. J. Wilson, R. de Waal Malefyt, R. A. Kastelein, and D. J. Cua. 2004. IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol. Rev. 202: 96-105.
48. Xia, C. Q., R. Peng, F. Beato, and M. J. Clare-Salzler. 2005. Dexamethasone induces IL-10-producing monocyte-derived dendritic cells with durable immaturity. Scand. J. Immunol. 62: 45-54.
49. Abe, M., and A. W. Thomson. 2003. Influence of immunosuppressive drugs on dendritic cells. Transpl. Immunol. 11: 357-365.
50. Weiner, H. L. 2001. Oral tolerance: immune mechanisms and the generation of Th3-type TGF-β-secreting regulatory cells. Microbes Infect. 3: 947-954.
51. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198: 1875-1886.
52. + T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J. Exp. Med. 195: 603-616.
53. + Tr cells. Blood 105: 1162-1169.
54. Fiorucci, S., E. Antonelli, E. Distrutti, P. Del Soldato, R. J. Flower, M. J. Clark, A. Morelli, M. Perretti, and L. J. Ignarro. 2002. NCX-1015, a nitric-oxide derivative of prednisolone, enhances regulatory T cells in the lamina propria and protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis in mice. Proc. Natl. Acad. Sci. USA 99: 15770-15775.
55. Feger, U., E. Tolosa, Y. H. Huang, A. Waschbisch, T. Biedermann, A. Melms, and H. Wiendl. 2007. HLA-G expression defines a novel regulatory T-cell subset present in human peripheral blood and sites of inflammation. Blood 110: 568-577.
56. Roncarolo, M. G., and S. Gregori. 2008. Is FOXP3 a bona fide marker for human regulatory T cells? Eur. J. Immunol. 38: 925-927.
57. Gavin, M. A., T. R. Torgerson, E. Houston, P. DeRoos, W. Y. Ho, A. Stray-Pedersen, E. L. Ocheltree, P. D. Greenberg, H. D. Ochs, and A. Y. Rudensky. 2006. Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc. Natl. Acad. Sci. USA 103: 6659-6664.
58. + regulatory T cells. J. Immunol. 172: 5986-5993.
59. Wakkach, A., N. Fournier, V. Brun, J. P. Breittmayer, F. Cottrez, and H. Groux. 2003. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 18: 605-617.